Skip to main content

VGM & ASSOCIATESHealthcare MSO

Search GO

Search GO

VGM & ASSOCIATESHealthcare MSO LEARN ABOUT VGM

Local Relationships Matter

Published in Government Relations on March 11, 2025

VGM Group, Inc is proud to announce that Rep. Miller-Meeks (R-IA) and Rep. Feenstra (R-IA) are lead sponsors of the DMEPOS Relief Act (H.R. 2005)! This bill will provide the 75/25 DME Relief and guide our work in the 119th Congress. Working alongside our industry partner, MAMES, VGM has long been cultivating relationships with the Iowa delegation with the hope that they will continue to be champions of change for the home medical equipment industry. Their support of DME suppliers is evident in their continued efforts to lead the passing of equitable reimbursement legislation.

Additional sponsors include Rep. Tonko (D-NY) and Rep. Panetta (D-CA). This gives us two members of Energy & Commerce and two members of Ways & Means championing our cause!

Both Representatives understand that people want to stay in their homes and live independently. The DME industry provides that opportunity, and we are honored to continue to partner with Rep. Miller-Meeks and Rep. Feenstra to create a robust, efficient, and effective home health experience for all people.

“Durable medical equipment like wheelchairs, oxygen tanks, walkers, and blood sugar monitors are critical for our seniors and Iowans recovering from surgery. However, our neighbors in rural communities face higher costs for these devices and DME providers often absorb these increased prices because of outdated reimbursement policies. That must change,” said Rep. Feenstra.

Feenstra John and ike Ike and MMM

"Several years ago, I made a six-hour drive to Hull, IA, to meet with a newly elected Representative. Meeting Representative Feenstra for the first time, I was impressed by his knowledge of healthcare and his commitment to supporting people in their homes. Fast forward to today, and we are thrilled to have Ways & Means member Rep. Feenstra championing the DMEPOS Relief Act (H.R. 2005). Adding to the strong Iowa connection is our friend and champion, Rep. Miller-Meeks. This VGM relationship began at the state level when she served in the Iowa Legislature. VGM is proud to collaborate with our Iowa Representatives, legislators across the country, industry stakeholders, and our members to be true Champions of Change." Ike Isaacson

We encourage you to reach out to your Representative today and ask them to support the DMEPOS Relief Act (H.R. 2005) and become a Champion of Change! Click here to contact your representative and urge them to support this crucial legislation.

From Our Experts

August Of Action: Your Chance To Connect With Congress thumbnail

August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you.

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail

Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications.

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail

HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry.

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk.

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review.

Evaluating the Value of a Payer Contract thumbnail

Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort.

Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

Give your business an advantage over the competition.

Become a Member